{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:26:40Z","timestamp":1776320800785,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Capital Clinical Diagnosis and Treatment Technology Research and Demonstration Application Project of China","award":["Z191100006619029"],"award-info":[{"award-number":["Z191100006619029"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2020YFC2008200"],"award-info":[{"award-number":["2020YFC2008200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s40123-022-00550-7","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:06:27Z","timestamp":1659078387000},"page":"1833-1845","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients"],"prefix":"10.1007","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct05408416","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Siying","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9975-1602","authenticated-orcid":false,"given":"Jinfeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"550_CR1","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","volume":"362","author":"W Yang","year":"2010","unstructured":"Yang W, Lu J, Weng J, Jia W, Ji L, Ji Q, Xiao J, Shan G, Shan Z, Liu J, Tian H, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, He J, China National D, Metabolic Disorders Study G. Prevalence of diabetes among men and women in China. New Engl J Med. 2010;362:1090\u2013101. https:\/\/doi.org\/10.1056\/NEJMoa0908292.","journal-title":"New Engl J Med"},{"key":"550_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/IAE.0b013e3181cd47a2","volume":"30","author":"VL Tseng","year":"2010","unstructured":"Tseng VL, Greenberg PB, Scott IU, Anderson KL. Compliance with the American academy of ophthalmology preferred practice pattern for diabetic retinopathy in a resident ophthalmology clinic. Retina (Philadelphia, Pa). 2010;30:787\u201394. https:\/\/doi.org\/10.1097\/IAE.0b013e3181cd47a2.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"550_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jamaophthalmol.2013.4154","volume":"131","author":"SB Bressler","year":"2013","unstructured":"Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG, Diabetic Retinopathy Clinical Research N. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. JAMA Ophthalmol. 2013;131:1033\u201340. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.4154.","journal-title":"JAMA Ophthalmol"},{"key":"550_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1755-3768.2008.01501.x","volume":"88","author":"R Ehrlich","year":"2010","unstructured":"Ehrlich R, Harris A, Ciulla TA, Kheradiya N, Winston DM, Wirostko B. Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process. Acta Ophthalmol (Oxford, Engl). 2010;88:279\u201391. https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01501.x.","journal-title":"Acta Ophthalmol (Oxford, Engl)"},{"key":"550_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ajo.2009.07.007","volume":"148","author":"X Wang","year":"2009","unstructured":"Wang X, Wang G, Wang Y. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2009;148:883\u20139. https:\/\/doi.org\/10.1016\/j.ajo.2009.07.007.","journal-title":"Am J Ophthalmol"},{"key":"550_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1097\/IAE.0000000000000058","volume":"34","author":"K Ferenchak","year":"2014","unstructured":"Ferenchak K, Duval R, Cohen JA, MacCumber MW. Intravitreal bevacizumab for postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy. Retina (Philadelphia, Pa). 2014;34:1177\u201381. https:\/\/doi.org\/10.1097\/IAE.0000000000000058.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"550_CR7","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/eye.2017.75","volume":"31","author":"O Comyn","year":"2017","unstructured":"Comyn O, Wickham L, Charteris DG, Sullivan PM, Ezra E, Gregor Z, Aylward GW, Da Cruz L, Fabinyi D, Peto T, Restori M, Xing W, Bunce C, Hykin PG, Bainbridge JW. Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study). Eye (Lond). 2017;31:1253\u20138. https:\/\/doi.org\/10.1038\/eye.2017.75.","journal-title":"Eye (Lond)"},{"key":"550_CR8","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1097\/IAE.0000000000000723","volume":"35","author":"MP Simunovic","year":"2015","unstructured":"Simunovic MP, Maberley DAL. Anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy a systematic review and meta-analysis. Retina (Philadelphia, Pa). 2015;35:1931\u201342. https:\/\/doi.org\/10.1097\/IAE.0000000000000723.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"550_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00417-010-1303-3","volume":"248","author":"R di Lauro","year":"2010","unstructured":"di Lauro R, De Ruggiero P, di Lauro R, di Lauro MT, Romano MR. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248:785\u201391. https:\/\/doi.org\/10.1007\/s00417-010-1303-3.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"550_CR10","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s41433-019-0396-0","volume":"33","author":"X Ren","year":"2019","unstructured":"Ren X, Bu S, Zhang X, Jiang Y, Tan L, Zhang H, Li X. Safety and efficacy of intravitreal conbercept injection after vitrectomy for the treatment of proliferative diabetic retinopathy. Eye (Lond). 2019;33:1177\u201383. https:\/\/doi.org\/10.1038\/s41433-019-0396-0.","journal-title":"Eye (Lond)"},{"key":"550_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000442773","volume":"56","author":"PJ Rosenfeld","year":"2016","unstructured":"Rosenfeld PJ, Durbin MK, Roisman L, Zheng F, Miller A, Robbins G, Schaal KB, Gregori G. ZEISS Angioplex\u2122 spectral domain optical coherence tomography angiography: technical aspects. Dev Ophthalmol. 2016;56:18.","journal-title":"Dev Ophthalmol"},{"key":"550_CR12","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.ophtha.2011.03.036","volume":"118","author":"J Ahn","year":"2011","unstructured":"Ahn J, Woo SJ, Chung H, Park KH. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy. Ophthalmology. 2011;118:2218\u201326. https:\/\/doi.org\/10.1016\/j.ophtha.2011.03.036.","journal-title":"Ophthalmology"},{"key":"550_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/IAE.0b013e3182979df6","volume":"34","author":"Y Suzuki","year":"2014","unstructured":"Suzuki Y, Suzuki K, Yokoi Y, Miyagawa Y, Metoki T, Nakazawa M. Effects of intravitreal injection of bevacizumab on inflammatory cytokines in the vitreous with proliferative diabetic retinopathy. Retina (Philadelphia, Pa). 2014;34:165\u201371. https:\/\/doi.org\/10.1097\/IAE.0b013e3182979df6.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"550_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"NMD Cheung","year":"2010","unstructured":"Cheung NMD, Mitchell PP, Wong TYP. Diabetic retinopathy. Lancet (Brit edn). 2010;376:124\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(09)62124-3.","journal-title":"Lancet (Brit edn)"},{"key":"550_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ajo.2010.03.016","volume":"150","author":"R-I Kohno","year":"2010","unstructured":"Kohno R-I, Hata Y, Mochizuki Y, Arita R, Kawahara S, Kita T, Miyazaki M, Hisatomi T, Ikeda Y, Aiello LP, Ishibashi T. Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection. Am J Ophthalmol. 2010;150:223-229.e221. https:\/\/doi.org\/10.1016\/j.ajo.2010.03.016.","journal-title":"Am J Ophthalmol"},{"key":"550_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1089\/jop.2021.0039","volume":"37","author":"L Chen","year":"2021","unstructured":"Chen L, Qu L, Gui Q, Wang S, Mao J, Fu X, Li W, Wang Y, Yi Q. Effects of anti-vascular endothelial growth factor drugs before and after pars plana vitrectomy in patients with polypoidal choroidal vasculopathy and vitreous hemorrhage. J Ocular Pharmacol Therap. 2021;37:591\u20136. https:\/\/doi.org\/10.1089\/jop.2021.0039.","journal-title":"J Ocular Pharmacol Therap"},{"key":"550_CR17","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1167\/iovs.15-17279","volume":"56","author":"Y Niwa","year":"2015","unstructured":"Niwa Y, Kakinoki M, Sawada T, Wang X, Ohji M. Ranibizumab and aflibercept: intraocular pharmacokinetics and their effects on aqueous vegf level in vitrectomized and nonvitrectomized macaque eyes. Invest Ophthalmol Vis Sci. 2015;56:6501\u20135. https:\/\/doi.org\/10.1167\/iovs.15-17279.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"550_CR18","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/IAE.0b013e3182753b12","volume":"33","author":"JB Christoforidis","year":"2013","unstructured":"Christoforidis JB, Williams MM, Wang J, Jiang A, Pratt C, Abdel-Rasoul M, Hinkle GH, Knopp MV. Anatomic and pharmacokinetic properties of intravitreal bevacizumab and ranibizumab after vitrectomy and lensectomy. Retina (Philadelphia, Pa). 2013;33:946\u201352. https:\/\/doi.org\/10.1097\/IAE.0b013e3182753b12.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"550_CR19","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1167\/iovs.12-10164","volume":"53","author":"M Kakinoki","year":"2012","unstructured":"Kakinoki M, Sawada O, Sawada T, Saishin Y, Kawamura H, Ohji M. Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys. Invest Ophthalmol Vis Sci. 2012;53:5877\u201380. https:\/\/doi.org\/10.1167\/iovs.12-10164.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"550_CR20","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/00006982-200507000-00002","volume":"25","author":"HS Chin","year":"2005","unstructured":"Chin HS, Park TS, Moon YS, Oh JH. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina. 2005;25:556\u201360. https:\/\/doi.org\/10.1097\/00006982-200507000-00002.","journal-title":"Retina"},{"key":"550_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ajo.2012.03.047","volume":"154","author":"TU Krohne","year":"2012","unstructured":"Krohne TU, Liu Z, Holz FG, Meyer CH. Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans. Am J Ophthalmol. 2012;154:682-686.e682. https:\/\/doi.org\/10.1016\/j.ajo.2012.03.047.","journal-title":"Am J Ophthalmol"},{"key":"550_CR22","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1097\/IAE.0000000000000617","volume":"35","author":"SBSB Bressler","year":"2015","unstructured":"Bressler SBSB, Melia MM, Glassman ARAR, Almukhtar TT, Jampol LMLM, Shami MM, Berger BBBB, Bressler NMNM. Ranibizumab plus prompt or deferred laser for diabetic macular edema in eyes with vitrectomy prior to anti-vascular endothelial growth factor therapy. Retina (Philadelphia, Pa). 2015;35:2516\u201328. https:\/\/doi.org\/10.1097\/IAE.0000000000000617.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"550_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10792-017-0462-1","volume":"38","author":"Y-Y Chen","year":"2017","unstructured":"Chen Y-Y, Chen P-Y, Chen F-T, Chen Y-J, Wang J-K. Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema. Int Ophthalmol. 2017;38:293\u20139. https:\/\/doi.org\/10.1007\/s10792-017-0462-1.","journal-title":"Int Ophthalmol"},{"key":"550_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000446992","volume":"236","author":"Y Koyanagi","year":"2016","unstructured":"Koyanagi Y, Yoshida S, Kobayashi Y, Kubo Y, Yamaguchi M, Nakama T, Nakao S, Ikeda Y, Ohshima Y, Ishibashi T, Sonoda K-h. Comparison of the effectiveness of intravitreal ranibizumab for diabetic macular edema in vitrectomized and nonvitrectomized eyes. Ophthalmologica (Basel). 2016;236:67\u201373. https:\/\/doi.org\/10.1159\/000446992.","journal-title":"Ophthalmologica (Basel)"},{"key":"550_CR25","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/IAE.0000000000002464","volume":"40","author":"G Rabina","year":"2020","unstructured":"Rabina G, Azem N, Barequet D, Barak A, Loewenstein A, Schwartz S. Silicone oil tamponade effect on macular layer thickness and visual acuity. Retina (Philadelphia, Pa). 2020;40:998\u20131004. https:\/\/doi.org\/10.1097\/IAE.0000000000002464.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"550_CR26","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1111\/aos.12307","volume":"92","author":"A Caramoy","year":"2014","unstructured":"Caramoy A, Droege KM, Kirchhof B, Fauser S. Retinal layers measurements in healthy eyes and in eyes receiving silicone oil-based endotamponade. Acta Ophthalmol (Oxford, Engl). 2014;92:e292\u20137. https:\/\/doi.org\/10.1111\/aos.12307.","journal-title":"Acta Ophthalmol (Oxford, Engl)"},{"key":"550_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/2474126418785538","volume":"2","author":"WJ Kheir","year":"2018","unstructured":"Kheir WJ, Mehanna C-J, Koaik M, Bashshur Z. Macular changes on optical coherence tomography before, during, and after silicone oil tamponade for macula-on retinal detachment: a case series. J Vitreo Retinal Dis. 2018;2:297\u2013301. https:\/\/doi.org\/10.1177\/2474126418785538.","journal-title":"J Vitreo Retinal Dis"},{"key":"550_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12886-020-01532-8","volume":"20","author":"Y Ding","year":"2020","unstructured":"Ding Y, Yao B, Hang H, Ye H. Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy. BMC Ophthalmol. 2020;20:292. https:\/\/doi.org\/10.1186\/s12886-020-01532-8.","journal-title":"BMC Ophthalmol"},{"key":"550_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225309","author":"Y Kameda","year":"2021","unstructured":"Kameda Y, Saeki T, Hanai K, Suzuki Y, Uchigata Y, Babazono T, Kitano S. Is chronic kidney disease affecting the postoperative complications of vitrectomy for proliferative diabetic retinopathy? J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10225309.","journal-title":"J Clin Med"},{"key":"550_CR30","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.ophtha.2019.08.010","volume":"128","author":"VH Gonzalez","year":"2021","unstructured":"Gonzalez VH, Wang P-w, Ruiz CQ. Panretinal photocoagulation for diabetic retinopathy in the RIDE and RISE trials: not \u201c1 and done.\u201d Ophthalmology (Rochester, Minn). 2021;128:1448\u201357. https:\/\/doi.org\/10.1016\/j.ophtha.2019.08.010.","journal-title":"Ophthalmology (Rochester, Minn)"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-022-00550-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-022-00550-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-022-00550-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T21:09:48Z","timestamp":1662066588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-022-00550-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1007\/s40123-022-00550-7","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"8 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}